Reproductive performance of Friesian mares after retained placenta and manual removal of the placenta.
Because the incidence of retained placenta in Friesian mares is estimated to be high, and no reports have been published on the reproductive performance of Friesian mares after retained placenta, we studied postpartum reproductive performance in Friesian brood mares with (n = 54) and without (n = 50) retained placenta. We defined a retained placenta as the failure to expel all fetal membranes within 3 h after the delivery of a foal. We subdivided the group of mares with retained placenta into mares in which the placenta had been removed manually (n = 30) and mares in which it had not (n = 24). Within each group, we compared reproductive performance after breeding in the foal heat and breeding in a subsequent heat. We also recorded the age of the mares, number of mares treated with antibiotics after insemination, and number of mares treated with prostaglandins. The interval between delivery and conception, efficacy rate (number of served cycles divided by the number of mares that had a positive pregnancy diagnosis), seasonal pregnancy rate, pregnancy rate after first insemination, pregnancy loss rate, and foaling rate did not differ between mares with and without retained placenta or between mares with and without manual removal of the retained placenta. Within each group, the pregnancy rate after first insemination did not differ between breeding for the first time in the foal heat and breeding for the first time in a subsequent heat. We concluded that reproductive performance did not differ between (1) Friesian mares with and without retained placenta and (2) Friesian mares with and without manual removal of the placenta. With regard to reproductive performance, retained placenta and manual removal of the placenta are not valid reasons to avoid foal heat breeding in Friesian mares.
Sevinga
M
M
Veterinary Practice Mid-Fryslân, Akkrum, The Netherlands. sevinga@xs4all.nl
Hesselink
J W
JW
Barkema
H W
HW
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001947:Breeding; D036861:Delivery, Obstetric / Q000662:veterinary; D005260:Female; D005306:Fertilization; D006734:Horse Diseases / Q000628:therapy*; D006736:Horses; D007315:Insemination, Artificial / Q000662:veterinary; D018457:Placenta, Retained / Q000150:complications / Q000628:therapy / Q000662:veterinary*; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage; D012098:Reproduction; D012621:Seasons; D013997:Time Factors
D000900:Anti-Bacterial Agents; D011453:Prostaglandins